Sevbind 400mg Tablet

Short Description

Sevbind 400mg Tablet is used to treat increased phosphate levels in the blood in patients who are on dialysis due to severe kidney disease.

Dosage Form

Tablet

Introduction

Sevbind 400mg Tablet is used to treat increased phosphate levels in the blood. It is used in patients who are on dialysis due to severe kidney disease. It inhibits the absorption of phosphate from the intestine and lowers the phosphate levels in the blood.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Sevbind 400mg Tablet is to be taken with food.

Side Effects

No common side effects listed.

Alcohol Warning

It is not known whether it is safe to consume alcohol with Sevbind 400mg Tablet. Please consult your doctor.

Breastfeeding Warning

Sevbind 400mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Pregnancy Warning

Sevbind 400mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Interacting Medicines

Mycophenolate mofetil Tacrolimus Ciclosporin

Sevbind 400mg Tablet inhibits the absorption of phosphate from the intestine and lower the phosphate levels in the blood.

You must take it with food and stick to the diet prescribed by your doctor. You may develop low levels of calcium, folic acid, and vitamins A, D, E, and K in your blood. Your doctor may prescribe supplements if necessary. Sevbind 400mg Tablet is used to control blood phosphate level in patients that are on dialysis treatment. Sevbind 400mg Tablet is used to control blood phosphate level in patients that are on dialysis treatment. Sevbind 400mg Tablet is used to control blood phosphate level in patients that are on dialysis treatment.